 Pamela Peterson
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 65 | 2023 | 1952 | 6.060 |
Why?
| | Defibrillators, Implantable | 30 | 2022 | 286 | 4.980 |
Why?
| | Cardiac Resynchronization Therapy | 9 | 2022 | 42 | 3.040 |
Why?
| | Registries | 41 | 2023 | 1760 | 2.410 |
Why?
| | Ventricular Dysfunction, Left | 13 | 2023 | 360 | 2.170 |
Why?
| | Death, Sudden, Cardiac | 15 | 2019 | 160 | 2.170 |
Why?
| | Stroke Volume | 25 | 2023 | 510 | 2.110 |
Why?
| | Sexual Dysfunction, Physiological | 3 | 2021 | 60 | 2.090 |
Why?
| | Bradycardia | 3 | 2021 | 48 | 1.940 |
Why?
| | Atrial Fibrillation | 8 | 2022 | 325 | 1.870 |
Why?
| | Hospitalization | 27 | 2023 | 1754 | 1.850 |
Why?
| | Cancer Survivors | 4 | 2024 | 206 | 1.840 |
Why?
| | Primary Prevention | 12 | 2019 | 171 | 1.770 |
Why?
| | Cardiology | 15 | 2022 | 259 | 1.760 |
Why?
| | American Heart Association | 18 | 2022 | 264 | 1.750 |
Why?
| | Cardiovascular Diseases | 14 | 2022 | 1729 | 1.660 |
Why?
| | Aged | 88 | 2023 | 19122 | 1.320 |
Why?
| | United States | 70 | 2023 | 12211 | 1.300 |
Why?
| | Healthcare Disparities | 7 | 2021 | 480 | 1.290 |
Why?
| | Cardiac Conduction System Disease | 2 | 2018 | 4 | 1.280 |
Why?
| | Myocardial Infarction | 19 | 2018 | 929 | 1.270 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 99 | 1.260 |
Why?
| | Practice Guidelines as Topic | 17 | 2019 | 1400 | 1.230 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 10 | 2023 | 180 | 1.220 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2018 | 79 | 1.220 |
Why?
| | Cardiac Rehabilitation | 3 | 2023 | 33 | 1.110 |
Why?
| | Humans | 154 | 2024 | 114937 | 1.080 |
Why?
| | Adrenergic beta-Antagonists | 10 | 2023 | 288 | 1.030 |
Why?
| | Patient Readmission | 9 | 2018 | 608 | 1.030 |
Why?
| | Guideline Adherence | 12 | 2019 | 490 | 1.000 |
Why?
| | Practice Patterns, Physicians' | 11 | 2020 | 1177 | 0.950 |
Why?
| | Medicare | 17 | 2023 | 666 | 0.930 |
Why?
| | Surgeons | 3 | 2022 | 237 | 0.930 |
Why?
| | Male | 94 | 2023 | 55663 | 0.900 |
Why?
| | Ventricular Function, Left | 7 | 2021 | 468 | 0.900 |
Why?
| | Female | 95 | 2023 | 59581 | 0.860 |
Why?
| | Health Status Disparities | 3 | 2021 | 201 | 0.840 |
Why?
| | Secondary Prevention | 6 | 2017 | 221 | 0.830 |
Why?
| | Patient Discharge | 15 | 2023 | 769 | 0.820 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 89 | 0.800 |
Why?
| | Middle Aged | 58 | 2022 | 26806 | 0.770 |
Why?
| | Cardiac Resynchronization Therapy Devices | 3 | 2020 | 10 | 0.770 |
Why?
| | Operating Rooms | 1 | 2022 | 87 | 0.760 |
Why?
| | Anemia | 4 | 2020 | 144 | 0.760 |
Why?
| | Aged, 80 and over | 35 | 2021 | 6364 | 0.760 |
Why?
| | Angiotensin Receptor Antagonists | 11 | 2023 | 76 | 0.740 |
Why?
| | Anti-Arrhythmia Agents | 4 | 2022 | 106 | 0.700 |
Why?
| | Neoplasms | 4 | 2024 | 2106 | 0.680 |
Why?
| | Retrospective Studies | 31 | 2023 | 12544 | 0.670 |
Why?
| | Hospitals | 7 | 2021 | 581 | 0.650 |
Why?
| | Heart Block | 1 | 2018 | 38 | 0.630 |
Why?
| | Ventricular Function | 1 | 2018 | 56 | 0.610 |
Why?
| | Risk Assessment | 15 | 2021 | 2975 | 0.610 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 20 | 0.610 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 20 | 0.610 |
Why?
| | Heart Conduction System | 1 | 2018 | 82 | 0.610 |
Why?
| | Cardiologists | 1 | 2018 | 40 | 0.600 |
Why?
| | Social Determinants of Health | 1 | 2020 | 135 | 0.600 |
Why?
| | Birth Certificates | 1 | 2017 | 8 | 0.590 |
Why?
| | Medicaid | 3 | 2021 | 407 | 0.590 |
Why?
| | Patient Compliance | 4 | 2017 | 526 | 0.570 |
Why?
| | Decision Support Techniques | 5 | 2022 | 352 | 0.570 |
Why?
| | Clinical Decision-Making | 3 | 2018 | 269 | 0.570 |
Why?
| | Peripheral Arterial Disease | 1 | 2023 | 380 | 0.570 |
Why?
| | Pregnancy Trimester, First | 1 | 2017 | 126 | 0.560 |
Why?
| | Congresses as Topic | 1 | 2018 | 198 | 0.560 |
Why?
| | Appointments and Schedules | 1 | 2017 | 73 | 0.560 |
Why?
| | Risk Factors | 28 | 2023 | 8637 | 0.550 |
Why?
| | Aminobutyrates | 6 | 2023 | 32 | 0.550 |
Why?
| | Treatment Outcome | 26 | 2023 | 9105 | 0.540 |
Why?
| | Critical Care | 2 | 2018 | 474 | 0.530 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1081 | 0.530 |
Why?
| | Hospital Mortality | 7 | 2019 | 776 | 0.520 |
Why?
| | Advisory Committees | 8 | 2022 | 208 | 0.510 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 122 | 0.500 |
Why?
| | Age Factors | 11 | 2020 | 2891 | 0.500 |
Why?
| | Reminder Systems | 1 | 2017 | 162 | 0.500 |
Why?
| | Prenatal Care | 1 | 2017 | 255 | 0.500 |
Why?
| | Outpatients | 4 | 2021 | 328 | 0.490 |
Why?
| | Waiting Lists | 1 | 2017 | 211 | 0.490 |
Why?
| | Cohort Studies | 21 | 2019 | 4903 | 0.490 |
Why?
| | Decision Making | 7 | 2022 | 781 | 0.490 |
Why?
| | Quality of Health Care | 6 | 2012 | 573 | 0.490 |
Why?
| | Patient Participation | 4 | 2022 | 360 | 0.490 |
Why?
| | Medication Adherence | 7 | 2021 | 537 | 0.480 |
Why?
| | Hemoglobins | 3 | 2020 | 314 | 0.460 |
Why?
| | Electrocardiography | 7 | 2021 | 562 | 0.460 |
Why?
| | Health Status Indicators | 3 | 2015 | 154 | 0.460 |
Why?
| | Insurance Coverage | 3 | 2021 | 202 | 0.430 |
Why?
| | Heart | 4 | 2023 | 609 | 0.430 |
Why?
| | Health Literacy | 2 | 2014 | 164 | 0.420 |
Why?
| | Heart-Assist Devices | 1 | 2018 | 485 | 0.410 |
Why?
| | Stress, Psychological | 1 | 2020 | 945 | 0.410 |
Why?
| | Diabetes Mellitus | 5 | 2023 | 904 | 0.410 |
Why?
| | Electric Countershock | 3 | 2019 | 104 | 0.400 |
Why?
| | Inpatients | 3 | 2023 | 380 | 0.390 |
Why?
| | Coronary Artery Disease | 3 | 2013 | 607 | 0.390 |
Why?
| | Minority Groups | 2 | 2021 | 228 | 0.390 |
Why?
| | Acculturation | 1 | 2012 | 50 | 0.380 |
Why?
| | Health Status | 6 | 2012 | 721 | 0.380 |
Why?
| | Health Services Accessibility | 1 | 2017 | 765 | 0.380 |
Why?
| | Valsartan | 5 | 2022 | 22 | 0.380 |
Why?
| | Quality of Life | 12 | 2024 | 2359 | 0.380 |
Why?
| | Time Factors | 15 | 2021 | 6125 | 0.380 |
Why?
| | Biphenyl Compounds | 5 | 2022 | 50 | 0.370 |
Why?
| | Heart Transplantation | 1 | 2017 | 667 | 0.370 |
Why?
| | Arrhythmias, Cardiac | 3 | 2019 | 279 | 0.360 |
Why?
| | Tetrazoles | 5 | 2023 | 32 | 0.360 |
Why?
| | Coronary Disease | 3 | 2008 | 347 | 0.360 |
Why?
| | Young Adult | 8 | 2024 | 10478 | 0.340 |
Why?
| | Sex Factors | 8 | 2018 | 1721 | 0.330 |
Why?
| | Metformin | 2 | 2023 | 278 | 0.330 |
Why?
| | Text Messaging | 2 | 2021 | 154 | 0.320 |
Why?
| | Catheter Ablation | 1 | 2012 | 291 | 0.320 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2023 | 486 | 0.300 |
Why?
| | Physician-Patient Relations | 4 | 2021 | 463 | 0.300 |
Why?
| | Quality Improvement | 4 | 2021 | 954 | 0.300 |
Why?
| | Adult | 22 | 2022 | 30608 | 0.290 |
Why?
| | Neprilysin | 4 | 2021 | 47 | 0.280 |
Why?
| | Survivors | 2 | 2009 | 411 | 0.280 |
Why?
| | Cross-Sectional Studies | 11 | 2022 | 4407 | 0.280 |
Why?
| | Equipment Design | 4 | 2017 | 511 | 0.270 |
Why?
| | Ventricular Remodeling | 2 | 2018 | 227 | 0.270 |
Why?
| | Follow-Up Studies | 13 | 2021 | 4427 | 0.270 |
Why?
| | Aftercare | 6 | 2023 | 187 | 0.270 |
Why?
| | Exercise Tolerance | 1 | 2008 | 213 | 0.270 |
Why?
| | Qualitative Research | 3 | 2021 | 936 | 0.260 |
Why?
| | Social Support | 5 | 2014 | 528 | 0.260 |
Why?
| | Mineralocorticoid Receptor Antagonists | 3 | 2020 | 38 | 0.260 |
Why?
| | Kidney Diseases | 1 | 2009 | 350 | 0.260 |
Why?
| | Self Care | 4 | 2018 | 350 | 0.250 |
Why?
| | Exercise Test | 4 | 2008 | 545 | 0.250 |
Why?
| | Prone Position | 1 | 2005 | 27 | 0.240 |
Why?
| | Informed Consent | 2 | 2023 | 161 | 0.240 |
Why?
| | Insurance, Health | 2 | 2017 | 244 | 0.240 |
Why?
| | Supine Position | 1 | 2005 | 33 | 0.240 |
Why?
| | Cardiovascular Agents | 2 | 2017 | 125 | 0.240 |
Why?
| | Diabetes Complications | 1 | 2006 | 211 | 0.240 |
Why?
| | Survival Rate | 7 | 2019 | 1644 | 0.240 |
Why?
| | Evidence-Based Medicine | 4 | 2013 | 675 | 0.240 |
Why?
| | Heart Diseases | 1 | 2008 | 330 | 0.240 |
Why?
| | Artifacts | 1 | 2005 | 113 | 0.230 |
Why?
| | Sex Characteristics | 1 | 2009 | 635 | 0.230 |
Why?
| | Survival Analysis | 6 | 2019 | 1220 | 0.230 |
Why?
| | Quality Assurance, Health Care | 4 | 2010 | 313 | 0.230 |
Why?
| | Incidence | 6 | 2019 | 2316 | 0.230 |
Why?
| | Adolescent | 6 | 2024 | 17829 | 0.230 |
Why?
| | Predictive Value of Tests | 7 | 2018 | 1801 | 0.230 |
Why?
| | Image Enhancement | 1 | 2005 | 162 | 0.230 |
Why?
| | Heart Rate | 3 | 2019 | 705 | 0.220 |
Why?
| | Odds Ratio | 7 | 2017 | 954 | 0.220 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2021 | 29 | 0.220 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 83 | 0.220 |
Why?
| | Drug Combinations | 5 | 2022 | 286 | 0.220 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2020 | 1215 | 0.220 |
Why?
| | Cardiac Surgical Procedures | 4 | 2010 | 414 | 0.220 |
Why?
| | Glomerular Filtration Rate | 2 | 2021 | 604 | 0.220 |
Why?
| | Social Class | 2 | 2017 | 204 | 0.220 |
Why?
| | Risk | 3 | 2019 | 815 | 0.220 |
Why?
| | Atherectomy | 1 | 2023 | 33 | 0.210 |
Why?
| | Prognosis | 9 | 2022 | 3344 | 0.210 |
Why?
| | Vascular Patency | 1 | 2023 | 97 | 0.210 |
Why?
| | Mortality | 4 | 2017 | 288 | 0.210 |
Why?
| | Popliteal Artery | 1 | 2023 | 57 | 0.210 |
Why?
| | Movement | 1 | 2005 | 244 | 0.210 |
Why?
| | Colorado | 6 | 2017 | 4091 | 0.210 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 54 | 0.210 |
Why?
| | Disposable Equipment | 1 | 2022 | 15 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2022 | 19 | 0.210 |
Why?
| | Longitudinal Studies | 5 | 2018 | 2382 | 0.200 |
Why?
| | Depression | 6 | 2012 | 1134 | 0.200 |
Why?
| | Refusal to Participate | 1 | 2021 | 6 | 0.200 |
Why?
| | Surveys and Questionnaires | 10 | 2022 | 4635 | 0.200 |
Why?
| | Adenoidectomy | 1 | 2022 | 61 | 0.200 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2096 | 0.200 |
Why?
| | Linear Models | 5 | 2017 | 770 | 0.200 |
Why?
| | Multivariate Analysis | 11 | 2017 | 1440 | 0.200 |
Why?
| | Child | 6 | 2022 | 18366 | 0.190 |
Why?
| | Hospital Costs | 1 | 2022 | 103 | 0.190 |
Why?
| | Exercise | 3 | 2009 | 1643 | 0.190 |
Why?
| | Femoral Artery | 1 | 2023 | 167 | 0.190 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2021 | 54 | 0.190 |
Why?
| | Intensive Care Units | 2 | 2018 | 619 | 0.190 |
Why?
| | Comorbidity | 7 | 2023 | 1458 | 0.190 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 40 | 0.190 |
Why?
| | Prospective Studies | 11 | 2018 | 6218 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 55 | 0.190 |
Why?
| | Interrupted Time Series Analysis | 1 | 2021 | 44 | 0.180 |
Why?
| | Manufacturing Industry | 1 | 2020 | 4 | 0.180 |
Why?
| | Clinical Trials as Topic | 4 | 2015 | 934 | 0.180 |
Why?
| | Chi-Square Distribution | 5 | 2017 | 495 | 0.180 |
Why?
| | Patient Care | 1 | 2021 | 103 | 0.180 |
Why?
| | Prosthesis Implantation | 2 | 2019 | 139 | 0.180 |
Why?
| | Protease Inhibitors | 1 | 2021 | 99 | 0.180 |
Why?
| | Groundwater | 1 | 2021 | 33 | 0.180 |
Why?
| | Goals | 2 | 2020 | 151 | 0.180 |
Why?
| | Algorithms | 2 | 2021 | 1474 | 0.180 |
Why?
| | Confidence Intervals | 2 | 2012 | 309 | 0.170 |
Why?
| | Research Personnel | 1 | 2021 | 151 | 0.170 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 139 | 0.170 |
Why?
| | Hypertension | 3 | 2021 | 1059 | 0.170 |
Why?
| | Income | 1 | 2020 | 167 | 0.170 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2020 | 53 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 250 | 0.160 |
Why?
| | Logistic Models | 7 | 2015 | 1844 | 0.160 |
Why?
| | Personal Satisfaction | 1 | 2020 | 182 | 0.160 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 479 | 0.160 |
Why?
| | Multimorbidity | 1 | 2019 | 33 | 0.160 |
Why?
| | Research Design | 2 | 2023 | 932 | 0.160 |
Why?
| | Antirheumatic Agents | 1 | 2021 | 255 | 0.160 |
Why?
| | Societies, Medical | 3 | 2019 | 677 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.160 |
Why?
| | Fraud | 1 | 2018 | 8 | 0.160 |
Why?
| | Postoperative Complications | 1 | 2009 | 2133 | 0.150 |
Why?
| | Hospitals, Rural | 1 | 2018 | 31 | 0.150 |
Why?
| | Patient Selection | 4 | 2021 | 642 | 0.150 |
Why?
| | Minority Health | 1 | 2018 | 19 | 0.150 |
Why?
| | Medical Overuse | 1 | 2018 | 31 | 0.150 |
Why?
| | Computers, Handheld | 1 | 2018 | 24 | 0.150 |
Why?
| | Social Values | 1 | 2018 | 36 | 0.150 |
Why?
| | Bundle-Branch Block | 2 | 2017 | 29 | 0.150 |
Why?
| | Hospitals, Urban | 1 | 2018 | 127 | 0.150 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 339 | 0.150 |
Why?
| | Subacute Care | 1 | 2018 | 71 | 0.150 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 126 | 0.150 |
Why?
| | Treatment Refusal | 2 | 2008 | 85 | 0.140 |
Why?
| | Cause of Death | 3 | 2019 | 363 | 0.140 |
Why?
| | Prevalence | 5 | 2022 | 2252 | 0.140 |
Why?
| | Coronary Angiography | 3 | 2008 | 306 | 0.140 |
Why?
| | Prosthesis Design | 1 | 2018 | 285 | 0.140 |
Why?
| | Nurse Practitioners | 1 | 2018 | 102 | 0.140 |
Why?
| | Thromboembolism | 1 | 2017 | 94 | 0.140 |
Why?
| | Warfarin | 1 | 2017 | 135 | 0.140 |
Why?
| | Length of Stay | 2 | 2018 | 949 | 0.130 |
Why?
| | Publishing | 1 | 2018 | 125 | 0.130 |
Why?
| | Proportional Hazards Models | 4 | 2019 | 1080 | 0.130 |
Why?
| | Medically Uninsured | 1 | 2017 | 122 | 0.130 |
Why?
| | Racism | 1 | 2018 | 102 | 0.130 |
Why?
| | Quality Indicators, Health Care | 1 | 2018 | 287 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 229 | 0.130 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2021 | 444 | 0.130 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 978 | 0.120 |
Why?
| | Mental Health | 1 | 2020 | 559 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 334 | 0.120 |
Why?
| | Kidney | 1 | 2021 | 1184 | 0.120 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 1183 | 0.110 |
Why?
| | Software | 1 | 2018 | 537 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2018 | 711 | 0.110 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2542 | 0.110 |
Why?
| | Hyperkalemia | 1 | 2013 | 26 | 0.110 |
Why?
| | Systole | 2 | 2013 | 171 | 0.110 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 119 | 0.110 |
Why?
| | Anticoagulants | 1 | 2017 | 547 | 0.110 |
Why?
| | Hemodialysis Units, Hospital | 1 | 2012 | 5 | 0.110 |
Why?
| | Vascular Access Devices | 1 | 2012 | 24 | 0.100 |
Why?
| | Medical Staff | 1 | 2012 | 16 | 0.100 |
Why?
| | Physicians | 1 | 2020 | 772 | 0.100 |
Why?
| | Communication | 1 | 2018 | 749 | 0.100 |
Why?
| | Antihypertensive Agents | 2 | 2023 | 429 | 0.100 |
Why?
| | Evidence-Based Practice | 2 | 2013 | 185 | 0.100 |
Why?
| | Models, Educational | 1 | 2012 | 85 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 2 | 2016 | 817 | 0.100 |
Why?
| | Stroke | 2 | 2017 | 1019 | 0.100 |
Why?
| | Drug Prescriptions | 1 | 2013 | 239 | 0.100 |
Why?
| | Angina Pectoris | 2 | 2010 | 63 | 0.100 |
Why?
| | Vocabulary | 1 | 2011 | 40 | 0.090 |
Why?
| | Pilot Projects | 3 | 2021 | 1372 | 0.090 |
Why?
| | Bacteremia | 1 | 2012 | 159 | 0.090 |
Why?
| | Peripheral Vascular Diseases | 1 | 2011 | 98 | 0.090 |
Why?
| | Ambulatory Care Facilities | 1 | 2012 | 213 | 0.090 |
Why?
| | Managed Care Programs | 1 | 2011 | 133 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2012 | 383 | 0.090 |
Why?
| | Renin-Angiotensin System | 2 | 2023 | 71 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2009 | 2770 | 0.090 |
Why?
| | Contraindications | 1 | 2010 | 85 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2015 | 473 | 0.090 |
Why?
| | Women's Health Services | 1 | 2010 | 15 | 0.090 |
Why?
| | Palliative Care | 2 | 2019 | 640 | 0.090 |
Why?
| | Diuretics | 2 | 2020 | 66 | 0.080 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 372 | 0.080 |
Why?
| | Probability | 1 | 2010 | 291 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2012 | 479 | 0.080 |
Why?
| | ROC Curve | 1 | 2009 | 448 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2011 | 342 | 0.080 |
Why?
| | Coronary Care Units | 1 | 2007 | 13 | 0.080 |
Why?
| | Emergency Service, Hospital | 2 | 2010 | 1813 | 0.080 |
Why?
| | Myocardial Reperfusion | 1 | 2007 | 49 | 0.070 |
Why?
| | Caregivers | 1 | 2014 | 714 | 0.070 |
Why?
| | Women's Health | 1 | 2010 | 271 | 0.070 |
Why?
| | Emotions | 1 | 2012 | 472 | 0.070 |
Why?
| | Chest Pain | 1 | 2007 | 81 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 638 | 0.070 |
Why?
| | Health Personnel | 1 | 2012 | 574 | 0.070 |
Why?
| | Myocardial Ischemia | 2 | 2019 | 234 | 0.070 |
Why?
| | Research Report | 2 | 2017 | 75 | 0.070 |
Why?
| | Weight Loss | 2 | 2009 | 642 | 0.070 |
Why?
| | Angina, Unstable | 1 | 2006 | 72 | 0.070 |
Why?
| | Consensus | 2 | 2019 | 534 | 0.070 |
Why?
| | Pregnancy | 1 | 2017 | 5527 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 336 | 0.060 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 64 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2006 | 151 | 0.060 |
Why?
| | Physical Endurance | 1 | 2006 | 231 | 0.060 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 50 | 0.060 |
Why?
| | Radionuclide Imaging | 1 | 2005 | 115 | 0.060 |
Why?
| | Heart Valves | 1 | 2005 | 41 | 0.060 |
Why?
| | Recovery of Function | 1 | 2008 | 572 | 0.060 |
Why?
| | Electronic Health Records | 1 | 2011 | 802 | 0.060 |
Why?
| | Depressive Disorder | 1 | 2007 | 332 | 0.060 |
Why?
| | Weight Gain | 1 | 2007 | 451 | 0.060 |
Why?
| | Acute Disease | 1 | 2006 | 915 | 0.060 |
Why?
| | Overweight | 1 | 2007 | 472 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 224 | 0.050 |
Why?
| | Biomedical Research | 1 | 2008 | 585 | 0.050 |
Why?
| | Sodium | 1 | 2023 | 182 | 0.050 |
Why?
| | Patients | 1 | 2024 | 162 | 0.050 |
Why?
| | Medical Oncology | 1 | 2024 | 228 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2021 | 48 | 0.050 |
Why?
| | Adhesives | 1 | 2021 | 11 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2021 | 25 | 0.050 |
Why?
| | Disease Management | 2 | 2017 | 563 | 0.050 |
Why?
| | Population Health | 1 | 2021 | 42 | 0.050 |
Why?
| | Trust | 1 | 2021 | 105 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1700 | 0.040 |
Why?
| | Transferrins | 1 | 2020 | 1 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.040 |
Why?
| | Forecasting | 1 | 2022 | 333 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 409 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 40 | 0.040 |
Why?
| | Ferritins | 1 | 2020 | 52 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 326 | 0.040 |
Why?
| | Patient Safety | 2 | 2012 | 278 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 277 | 0.040 |
Why?
| | Aspirin | 2 | 2015 | 324 | 0.040 |
Why?
| | United States Government Agencies | 1 | 2018 | 6 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 546 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2010 | 539 | 0.040 |
Why?
| | Cardiovascular Nursing | 1 | 2018 | 3 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 897 | 0.040 |
Why?
| | Transitional Care | 1 | 2018 | 34 | 0.040 |
Why?
| | Focus Groups | 1 | 2020 | 385 | 0.040 |
Why?
| | F Factor | 1 | 2017 | 3 | 0.040 |
Why?
| | Tachycardia, Ventricular | 1 | 2019 | 153 | 0.040 |
Why?
| | Health Facility Size | 1 | 2017 | 12 | 0.040 |
Why?
| | Biomarkers | 2 | 2017 | 3418 | 0.040 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 254 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2020 | 351 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 1856 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 336 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2017 | 102 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 2017 | 82 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2023 | 1008 | 0.030 |
Why?
| | Information Dissemination | 1 | 2018 | 188 | 0.030 |
Why?
| | Skilled Nursing Facilities | 1 | 2017 | 121 | 0.030 |
Why?
| | Administration, Oral | 1 | 2017 | 731 | 0.030 |
Why?
| | Frail Elderly | 1 | 2015 | 105 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1593 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 947 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2018 | 583 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 228 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3248 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1125 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1325 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1477 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 130 | 0.030 |
Why?
| | Potassium | 1 | 2013 | 128 | 0.030 |
Why?
| | Hemorrhage | 1 | 2017 | 618 | 0.030 |
Why?
| | Dementia | 1 | 2015 | 186 | 0.030 |
Why?
| | Propensity Score | 1 | 2014 | 224 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 372 | 0.030 |
Why?
| | Pacific States | 1 | 2012 | 7 | 0.030 |
Why?
| | Needs Assessment | 1 | 2014 | 315 | 0.030 |
Why?
| | New England | 1 | 2012 | 27 | 0.030 |
Why?
| | Health Maintenance Organizations | 1 | 2012 | 93 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2012 | 57 | 0.030 |
Why?
| | Recurrence | 1 | 2015 | 937 | 0.030 |
Why?
| | Creatinine | 1 | 2013 | 424 | 0.020 |
Why?
| | Education | 1 | 2012 | 95 | 0.020 |
Why?
| | History, 21st Century | 1 | 2012 | 161 | 0.020 |
Why?
| | Internationality | 1 | 2012 | 144 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2013 | 248 | 0.020 |
Why?
| | Infection Control | 1 | 2012 | 135 | 0.020 |
Why?
| | History, 20th Century | 1 | 2012 | 267 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 400 | 0.020 |
Why?
| | Drug Utilization | 1 | 2012 | 167 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5035 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2012 | 107 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 460 | 0.020 |
Why?
| | Lung Diseases | 1 | 2017 | 703 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 187 | 0.020 |
Why?
| | Poisson Distribution | 1 | 2010 | 72 | 0.020 |
Why?
| | Renal Dialysis | 1 | 2012 | 369 | 0.020 |
Why?
| | Terminal Care | 1 | 2012 | 213 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2009 | 60 | 0.020 |
Why?
| | Infant | 1 | 2021 | 7937 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9086 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 928 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2008 | 67 | 0.020 |
Why?
| | Databases as Topic | 1 | 2007 | 63 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 2008 | 122 | 0.020 |
Why?
| | Reperfusion | 1 | 2006 | 36 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2009 | 232 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2010 | 634 | 0.020 |
Why?
| | Clinical Competence | 1 | 2012 | 901 | 0.020 |
Why?
| | Family | 1 | 2009 | 590 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2009 | 476 | 0.020 |
Why?
| | California | 1 | 2006 | 363 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2007 | 582 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2005 | 198 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 374 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2009 | 655 | 0.010 |
Why?
| | Anxiety | 1 | 2009 | 846 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2009 | 834 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1077 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1537 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 1821 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 1961 | 0.010 |
Why?
| | Obesity | 1 | 2007 | 2514 | 0.010 |
Why?
|
|
Peterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|